Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.820
-0.040 (-0.82%)
Apr 24, 2026, 4:25 PM CET
Market Cap1.76B +154.5%
Revenue (ttm)839.00K
Net Income-58.01M
EPS-0.17
Shares Out361.38M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,432,095
Average Volume2,810,545
Open4.940
Previous Close4.860
Day's Range4.750 - 4.940
52-Week Range2.230 - 5.730
Beta-0.21
RSI48.45
Earnings DateAug 28, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 18
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements